Remdesivir Use in the Real-World Setting: An Overview of Available Evidence

K Akinosoglou, EA Rigopoulos, G Schinas, G Kaiafa… - Viruses, 2023 - mdpi.com
In the years of Coronavirus Disease 2019 (COVID-19), various treatment options have been
utilized. COVID-19 continues to circulate in the global population, and the evolution of the …

Remdesivir for the Treatment of COVID-19: A Narrative Review

PO Godwin, B Polsonetti, MF Caron… - Infectious Diseases and …, 2024 - Springer
Despite the wide availability of effective vaccines, COVID-19 continues to be an infectious
disease of global importance. Remdesivir is a broad-spectrum antiviral and was the first US …

Association of renal function with mortality among hospitalized patients treated with remdesivir for COVID-19

ML Gonzalez Suarez, KC Mara, CG Rivera… - Plos one, 2024 - journals.plos.org
Background and aim Renal dysfunction is associated with poor outcomes in patients with
coronavirus disease 2019 (COVID-19). In an effort to improve outcomes, intravenous …

[HTML][HTML] Clinical outcomes and safety of remdesivir in hospitalized individuals with COVID-19, with or without severe renal impairment

MC Chang, PF Wu, YC Ho, WY Lin, CY Wu… - Journal of Infection and …, 2024 - Elsevier
Background The use of remdesivir in patients with coronavirus disease 2019 (COVID-19)
and severe renal impairment has been approved; however, limited clinical data exist …